The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo
Online Katalog der Universitätsbibliothek der LMU München (1/1)
Ablegen in:
The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo
The addition of the novel heparan sulfate (HS) mimetic PG545 to standard chemotherapy shows promising efficacy in the treatment of ovarian cancer in vitro and in vivo